Your browser doesn't support javascript.
loading
A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine.
Hattori, Keiichiro; Sakata-Yanagimoto, Mamiko; Okoshi, Yasushi; Kato, Takayasu; Kurita, Naoki; Yokoyama, Yasuhisa; Obara, Naoshi; Takano, Shingo; Ishikawa, Eiichi; Yamamoto, Tetsuya; Matsumura, Akira; Hasegawa, Yuichi; Chiba, Shigeru.
Afiliação
  • Hattori K; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
  • Sakata-Yanagimoto M; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
  • Okoshi Y; Ibaraki Clinical Education and Training Center, University of Tsukuba Hospital; Department of Hematology, Ibaraki Prefectural Central Hospital.
  • Kato T; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
  • Kurita N; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
  • Yokoyama Y; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
  • Obara N; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
  • Takano S; Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba.
  • Ishikawa E; Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba.
  • Yamamoto T; Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba.
  • Matsumura A; Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba.
  • Hasegawa Y; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
  • Chiba S; Department of Clinical and Experimental Hematology, Institute of Clinical Medicine, University of Tsukuba.
J Clin Exp Hematop ; 57(2): 41-46, 2017 Oct 12.
Article em En | MEDLINE | ID: mdl-28781291
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 11_ODS3_cobertura_universal / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 11_delivery_arrangements / 6_lymphomas_multiple_myeloma Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Sistema Nervoso Central / Citarabina / Quimiorradioterapia / Linfoma Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Exp Hematop Assunto da revista: HEMATOLOGIA / PATOLOGIA Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 11_ODS3_cobertura_universal / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 11_delivery_arrangements / 6_lymphomas_multiple_myeloma Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Sistema Nervoso Central / Citarabina / Quimiorradioterapia / Linfoma Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Exp Hematop Assunto da revista: HEMATOLOGIA / PATOLOGIA Ano de publicação: 2017 Tipo de documento: Article